A Cross-Modal Mutual Knowledge Distillation Framework for Alzheimer's Disease Diagnosis: Addressing Incomplete Modalities
- PMID: 40893870
- PMCID: PMC12393172
- DOI: 10.1109/tase.2025.3556290
A Cross-Modal Mutual Knowledge Distillation Framework for Alzheimer's Disease Diagnosis: Addressing Incomplete Modalities
Abstract
Early detection of Alzheimer's Disease (AD) is crucial for timely interventions and optimizing treatment outcomes. Integrating multimodal neuroimaging datasets can enhance the early detection of AD. However, models must address the challenge of incomplete modalities, a common issue in real-world scenarios, as not all patients have access to all modalities due to practical constraints such as cost and availability. We propose a deep learning framework employing Incomplete Cross-modal Mutual Knowledge Distillation (IC-MKD) to model different sub-cohorts of patients based on their available modalities. In IC-MKD, the multimodal model (e.g., MRI and PET) serves as a teacher, while the single-modality model (e.g., MRI only) is the student. Our IC-MKD framework features three components: a Modality-Disentangling Teacher (MDT) model designed through information disentanglement, a student model that learns from classification errors and MDT's knowledge, and the teacher model enhanced via distilling the student's single-modal feature extraction capabilities. Moreover, we show the effectiveness of the proposed method through theoretical analysis and validate its performance with simulation studies. In addition, our method is demonstrated through a case study with Alzheimer's Disease Neuroimaging Initiative (ADNI) datasets, underscoring the potential of artificial intelligence in addressing incomplete multimodal neuroimaging datasets and advancing early AD detection.
Keywords: Alzheimer’s disease; incomplete multimodal datasets; knowledge distillation; mild cognitive impairment; representation disentanglement.
Update of
-
A Cross-Modal Mutual Knowledge Distillation Framework for Alzheimer's Disease Diagnosis: Addressing Incomplete Modalities.medRxiv [Preprint]. 2024 Oct 22:2023.08.24.23294574. doi: 10.1101/2023.08.24.23294574. medRxiv. 2024. Update in: IEEE Trans Autom Sci Eng. 2025;22:14218-14233. doi: 10.1109/tase.2025.3556290. PMID: 37662267 Free PMC article. Updated. Preprint.
Similar articles
-
A Cross-Modal Mutual Knowledge Distillation Framework for Alzheimer's Disease Diagnosis: Addressing Incomplete Modalities.medRxiv [Preprint]. 2024 Oct 22:2023.08.24.23294574. doi: 10.1101/2023.08.24.23294574. medRxiv. 2024. Update in: IEEE Trans Autom Sci Eng. 2025;22:14218-14233. doi: 10.1109/tase.2025.3556290. PMID: 37662267 Free PMC article. Updated. Preprint.
-
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6. J Prev Alzheimers Dis. 2025. PMID: 39920001 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629415 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Roy S, Wang J, and Xu Y, “Alzheimer’s disease facts and figures,” Alzheimers Dement, vol. 19, pp. 1598–1695, 2023. - PubMed
-
- Canady VA, “Fda approves new treatment for alzheimer’s disease,” Mental Health Weekly, vol. 33, no. 3, pp. 6–7, 2023.